Answers are grounded in this paper and cite their sources.
Assessment of sustained remission using the CDAI, SDAI, or Boolean criteria is more stringent, yet congruous with the DAS28-based criteria in RA patients treated with b/tsDMARDs.
No takes yet. Share an insight, caveat, or question.
Koh et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: